Blockchain Registration Transaction Record

Apimeds' NILA Token to List on Pionex Exchange Oct. 14, 2026

Apimeds' NILA token from MindWave Innovations will list on Pionex Oct. 14, 2026, expanding access ahead of its MindChain Layer 2 migration and enterprise blockchain plans.

The listing of NILA on Pionex is a significant milestone for Apimeds Pharmaceuticals and its subsidiary MindWave Innovations, as it opens the token to a wider global audience and provides a tangible step toward the eventual launch of the MindChain Layer 2 network. For investors, this event could enhance liquidity and trading opportunities for NILA, while also serving as a public validation of MindWave’s enterprise blockchain strategy. The development of dedicated networks like AQUAEChain, FlashChain, and AssureChain suggests that MindChain is targeting real-world business applications, not just speculative crypto use. This matters because successful enterprise adoption of blockchain could drive demand for NILA’s utility in transaction fees, staking, and governance. Moreover, the involvement of MindWaveDAO gives token holders a direct say in ecosystem funding and direction, which may appeal to those who value decentralized governance. As with any crypto listing, regulatory and technical risks remain, but the move signals growing maturity and ambition in Apimeds’ blockchain endeavors.